Evercore ISI Removes West Pharmaceutical (WST) from Tactical Outperform List

October 27, 2025 7:04 AM EDT Send to a Friend
Evercore ISI analyst Daniel Markowitz reiterated an Outperform rating and $390.00 price target on West Pharmaceutical (NYSE: WST).The analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login